{"id":467,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","title":{"rendered":"MK-677 \/ Ibutamoren\u00a0: \u00e9tat clinique, signal d'insuffisance cardiaque et questions mat\u00e9rielles"},"content":{"rendered":"
MK-677, MK-0677 et ibutamoren sont des noms que l'on retrouve dans la m\u00eame histoire de d\u00e9veloppement. L\u2019existence d\u2019essais sur l\u2019homme ne signifie pas que le compos\u00e9 est un m\u00e9dicament approuv\u00e9, ni n\u2019efface les essais qui n\u2019ont pas d\u00e9montr\u00e9 de b\u00e9n\u00e9fice fonctionnel ou qui ont soulev\u00e9 des probl\u00e8mes de s\u00e9curit\u00e9.<\/p>
Ce que montre le dossier<\/h2>
L'Ibutamoren n'est pas un ingr\u00e9dient actif approuv\u00e9 par FDA.<\/li>
Un essai sur une fracture de la hanche chez un patient 123 a \u00e9t\u00e9 arr\u00eat\u00e9 t\u00f4t apr\u00e8s un signal d'insuffisance cardiaque congestive.<\/li>
L'identit\u00e9 et le dosage doivent distinguer la forme libre de l'ibutamor\u00e8ne du m\u00e9sylate d'ibutamor\u00e8ne.<\/li><\/ul><\/div><\/div>Illustration \u00e9ditoriale originale utilis\u00e9e pour identifier le th\u00e8me de recherche. Il ne d\u00e9crit pas un lot catalogue, un m\u00e9dicament approuv\u00e9, un r\u00e9sultat de test ou une utilisation clinique.<\/figcaption><\/figure>
La fronti\u00e8re entre l\u2019identit\u00e9 et la preuve<\/h2>
Un certificat doit indiquer la forme mol\u00e9culaire exacte et ne pas utiliser le nom parent et le m\u00e9sylate de mani\u00e8re interchangeable. La masse mol\u00e9culaire, le calcul du dosage et le contenu par conteneur d\u00e9pendent de ce choix.<\/p>
Synonymes dans la litt\u00e9rature<\/strong>MK-677, MK-0677, ibutamoren<\/span><\/div>
Probl\u00e8me de sel\/forme<\/strong>Ibutamoren vs m\u00e9sylate d'ibutamoren<\/span><\/div>
Contexte de s\u00e9curit\u00e9<\/strong>Effets glucose\/insuline, \u0153d\u00e8me et signal CHF<\/span><\/div><\/div><\/div>
Ce qui appartient au dossier mat\u00e9riel<\/h2>
Les r\u00e9sum\u00e9s marketing s\u00e9lectionnent fr\u00e9quemment l\u2019augmentation du IGF-1 ou de la masse maigre et omettent les r\u00e9sultats fonctionnels n\u00e9gatifs. Une page d\u00e9fendable maintient intacte la hi\u00e9rarchie des r\u00e9sultats et cite l\u2019essai interrompu sur une fracture de la hanche ainsi que l\u2019\u00e9tude plus longue men\u00e9e aupr\u00e8s d\u2019adultes \u00e2g\u00e9s en bonne sant\u00e9.<\/p>
R\u00e8gle \u00e9ditoriale<\/h2>
Utilisez le nom exact de l\u2019intervention, le mod\u00e8le, la population et le point final de l\u2019enregistrement cit\u00e9. Ne convertissez pas une association, un m\u00e9canisme, un r\u00e9sultat animal, un dossier de m\u00e9dicament fini approuv\u00e9 ou un test analytique en une all\u00e9gation concernant un lot du catalogue sans rapport.<\/p>","protected":false},"excerpt":{"rendered":"
MK-677, MK-0677 et ibutamoren sont des noms que l'on retrouve dans la m\u00eame histoire de d\u00e9veloppement. L\u2019existence d\u2019essais sur l\u2019homme ne signifie pas que le compos\u00e9 est un m\u00e9dicament approuv\u00e9, ni n\u2019efface les essais qui n\u2019ont pas d\u00e9montr\u00e9 de b\u00e9n\u00e9fice fonctionnel ou qui ont soulev\u00e9 des probl\u00e8mes de s\u00e9curit\u00e9.<\/p>","protected":false},"author":1,"featured_media":632,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"351","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Randomized trials and FDA compounding review","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"MK-677 in healthy older adults: two-year randomized trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18981485\/\",\"note\":\"Body composition, function and glucose findings; PMID 18981485.\"},{\"title\":\"MK-0677 phase IIb hip-fracture study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21067829\/\",\"note\":\"Early termination after CHF signal; PMID 21067829.\"},{\"title\":\"FDA Pharmacy Compounding Advisory Committee meeting materials\",\"url\":\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/october-29-2024-meeting-pharmacy-compounding-advisory-committee-10292024\",\"note\":\"FDA assessment materials for ibutamoren and ipamorelin.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"\n
MK-677 Clinical Status, Safety Signals & Quality Questions<\/title>\n<meta name=\"description\" content=\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/fr\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\" \/>\n<meta property=\"og:description\" content=\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/fr\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"MK-677 \\\/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"},\"wordCount\":242,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"articleSection\":[\"Evidence & Quality Guides\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\",\"name\":\"MK-677 Clinical Status, Safety Signals & Quality Questions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MK-677 \\\/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/fr\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00c9tat clinique de MK-677, signaux de s\u00e9curit\u00e9 et questions sur la qualit\u00e9","description":"MK-677, MK-0677 et ibutamoren sont des noms que l'on retrouve dans la m\u00eame histoire de d\u00e9veloppement. L\u2019existence d\u2019essais sur l\u2019homme ne signifie pas que le compos\u00e9 est approuv\u00e9\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/fr\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","og_locale":"fr_FR","og_type":"article","og_title":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions","og_description":"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026","og_url":"https:\/\/nhdbio.com\/fr\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u00c9crit par":"NHD Technical Team","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"wordCount":242,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","articleSection":["Evidence & Quality Guides"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","url":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","name":"\u00c9tat clinique de MK-677, signaux de s\u00e9curit\u00e9 et questions sur la qualit\u00e9","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"MK-677, MK-0677 et ibutamoren sont des noms que l'on retrouve dans la m\u00eame histoire de d\u00e9veloppement. L\u2019existence d\u2019essais sur l\u2019homme ne signifie pas que le compos\u00e9 est approuv\u00e9\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mati\u00e8res premi\u00e8res peptidiques et synth\u00e8se sur mesure","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u00c9quipe technique NHD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"L'\u00e9quipe technique NHD maintient la documentation du catalogue d'utilisation de la recherche et les r\u00e9sum\u00e9s des preuves. Les articles examin\u00e9s renvoient \u00e0 des articles \u00e9valu\u00e9s par des pairs, \u00e0 des registres d'essais et \u00e0 des dossiers r\u00e9glementaires, conservent les r\u00e9sultats nuls et les limites des \u00e9tudes, et distinguent les interventions publi\u00e9es des documents du catalogue. Le dessin assist\u00e9 par AI peut \u00eatre utilis\u00e9 pour la structure\u00a0; les liens vers les sources et les limites des preuves restent visibles. Ce travail ne constitue pas un examen ind\u00e9pendant par des pairs ni un avis m\u00e9dical.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/fr\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/comments?post=467"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/467\/revisions"}],"predecessor-version":[{"id":509,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/467\/revisions\/509"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media\/632"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media?parent=467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/categories?post=467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/tags?post=467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Un](\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png\")